unrv-20230630

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ____________ to ____________

Commission File Number: 000-54258


			UNRIVALED BRANDS, INC.
			(Exact Name of Registrant as Specified in its Charter)


Nevada						26-3062661
(State or Other Jurisdiction of Incorporation or Organization)						(I.R.S. Employer Identification No.)


3242 S. Halladay Street, Suite 202 Santa Ana, California						92705
(Address of Principal Executive Offices)						(Zip Code)

(888) 909-5564

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange
on which registered

Common Stock, par value $0.001

UNRV

OTCQB

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:


Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x	Smaller reporting company	x
Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of August 10, 2023, there were 772,483,465 shares of common stock outstanding, 100,918,457 shares of common stock issuable upon the exercise of all our outstanding warrants, and 21,125,759 shares of common stock issuable upon the exercise of all vested options.

Table of Contents

UNRIVALED BRANDS, INC.

INDEX TO FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023


	PART I – FINANCIAL INFORMATION
		Page
Item 1.	Financial Statements
	Consolidated Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022	4
	Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2023 and 2022 (Unaudited)	5
	Consolidated Statements of Stockholders' (Deficit) Equity for the Three Months Ended June 30, 2023 and 2022 (Unaudited)	6
	Consolidated Statements of Stockholders' (Deficit) Equity for the Six Months Ended June 30, 2023 and 2022 (Unaudited)	7
	Consolidated Statements of Cash Flows for the Six Months Ended June 30 , 2023 and 2022 (Unaudited)	8
	Notes to Consolidated Financial Statements (Unaudited)	9
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	27
	Company Overview	27
	Results of Operations	29
	Liquidity, Capital Resources and Going Concern	35
	Critical Accounting Policies and Estimates	36
	Disclosure About Off-Balance Sheet Arrangements	36
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	36
Item 4.	Controls and Procedures	36

	PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	38
Item 1A.	Risk Factors	38
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38
Item 3.	Defaults Upon Senior Securities	38
Item 4.	Mine Safety Disclosures	38
Item 5.	Other Information	39
Item 6.	Exhibits	40
Signatures		41

Table of Contents

Cautionary Note Concerning Forward-Looking Statements

In addition to historical information, this Quarterly Report on Form 10-Q may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which provides a “safe harbor” for forward-looking statements made by us. All statements, other than statements of historical facts, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, results of operations, financial position, business outlook, business trends, and other information, may be forward-looking statements. Words such as “might,” “will,” “may,” “should,” “estimates,” “expects,” “continues,” “contemplates,” “anticipates,” “projects,” “plans,” “potential,” “predicts,” “intends,” “believes,” “forecasts,” “future,” and variations of such words or similar expressions are intended to identify forward-looking statements. The forward-looking statements are not historical facts, and are based upon our current expectations, beliefs, estimates and projections, and various assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates, and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, estimates, and projections will occur or can be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.

There are a number of risks, uncertainties, and other important factors, many of which are beyond our control, that could cause actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q. Such risks, uncertainties, and other important factors that could cause actual results to differ include, among others, the risk, uncertainties and factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 and in other filings we make from time to time with the U.S. Securities and Exchange Commission (“SEC”).

We caution you that the risks, uncertainties, and other factors set forth in our periodic filings with the SEC may not contain all of the risks, uncertainties, and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits, or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. There can be no assurance that: (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct, or (iv) our strategy, which is based in part on this analysis, will be successful. All forward-looking statements in this report apply only as of the date of the report or as of the date they were made and, except as required by applicable law, we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise.

Table of Contents

ITEM 1. FINANCIAL STATEMENTS.

UNRIVALED BRANDS, INC.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(in thousands, except for shares)


	June 30, 2023		December 31, 2022
	(Unaudited)
ASSETS
Current Assets:
Cash and Cash Equivalents	$	588	$	1,200
Accounts Receivable	862		313
Inventory	2,952		1,939
Prepaid Expenses & Other Assets	691		498
Notes Receivable	625		625
Total Current Assets	5,718		4,575

Property, Equipment and Leasehold Improvements, Net	12,577		13,000
Intangible Assets, Net	1,734		2,859
Goodwill	3,585		3,585
Other Assets	14,646		16,279
Investments	—		210
TOTAL ASSETS	$	38,260	$	40,508

LIABILITIES AND STOCKHOLDERS’ DEFICIT
LIABILITIES:
Current Liabilities:
Accounts Payable	$	10,425	$	12,990
Accrued Liabilities	5,608		4,424
Current Lease Liabilities	2,133		1,996
Current Portion of Notes Payable	25,879		29,662
Income Taxes Payable	8,771		10,071
Total Current Liabilities	52,816		59,143

Notes Payable, Net of Discounts	6,642		4,814
Lease Liabilities	12,304		13,088
TOTAL LIABILITIES	71,762		77,045

COMMITMENTS AND CONTINGENCIES (Note 18)	—		—

STOCKHOLDERS’ DEFICIT:
Preferred Stock, Convertible Series V, par value $0.001:
25,000,000 shares authorized; 14,071,431 and nil shares outstanding as of June 30, 2023 and December 31, 2022, respectively	1		—
Common Stock, par value $0.001:
990,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 772,483,465 and 679,513,554 shares outstanding as of June 30, 2023 and December 31, 2022, respectively	797		701
Treasury Stock: nil and 2,308,420 shares of common stock as of June 30, 2023 and December 31, 2022, respectively	—		(808)
Additional Paid-In Capital	406,781		403,619
Accumulated Deficit	(441,081)		(440,049)
TOTAL STOCKHOLDERS’ DEFICIT	(33,502)		(36,537)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	38,260	$	40,508

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

UNRIVALED BRANDS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(in thousands, except for shares and per share data)


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022

Revenue	$	8,797	$	15,801	$	18,037	$	34,650
Cost of Goods Sold	4,197		7,714		8,742		20,450
Gross Profit	4,600		8,087		9,295		14,200

Operating Expenses:
Selling, General & Administrative	8,071		18,160		13,668		36,091
Impairment Expense	—		55,726		—		55,726
(Gain) Loss on Disposal of Assets	(1,739)		541		(1,739)		343
Total Operating Expenses	6,332		74,427		11,929		92,160

Loss from Operations	(1,732)		(66,340)		(2,634)		(77,960)

Other Income (Expense):
Interest Expense, Net	(187)		(438)		(1,211)		(2,204)
Gain on Extinguishment of Debt	—		—		3,026		542
Gain on Settlement of Liabilities	110		—		110		—
Realized Loss on Sale of Investments	—		—		(61)		—
Unrealized Gain on Investments	—		963		—		963
Other Income	242		230		271		858
Total Other Income, Net	165		755		2,135		159

Loss from Continuing Operations Before Provision for Income Taxes	(1,567)		(65,585)		(499)		(77,801)
Provision for Income Tax Benefit (Expense) for Continuing Operations	125		448		(533)		2,136
Net Loss from Continuing Operations	(1,442)		(65,137)		(1,032)		(75,665)

Income from Discontinued Operations Before Provision for Income Taxes	—		1,419		—		3,349
Net Income from Discontinued Operations	—		1,419		—		3,349

NET LOSS	$	(1,442)	$	(63,718)	$	(1,032)	$	(72,316)

Less: Net Income from Discontinued Operations Attributable to Non-Controlling Interest	—		—		—		275
NET LOSS ATTRIBUTABLE TO UNRIVALED BRANDS, INC.	$	(1,442)	$	(63,718)	$	(1,032)	$	(72,591)

Net Loss from Continuing Operations per Common Share Attributable to Unrivaled Brands, Inc. - Basic and Diluted	$	—	$	(0.11)	$	—	$	(0.13)
Net Loss per Common Share Attributable to Unrivaled Brands, Inc. - Basic and Diluted	$	—	$	(0.11)	$	—	$	(0.13)
Weighted-Average Shares Outstanding - Basic	835,274,484		575,973,609		851,619,604		572,176,041
Weighted-Average Shares Outstanding - Diluted	835,274,484		575,973,609		851,619,604		572,176,041

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

UNRIVALED BRANDS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (UNAUDITED)

FOR THE THREE MONTHS ENDED JUNE 30, 2023 AND 2022

(in thousands, except for shares)


	Convertible Series V Preferred Stock			Common Stock			Treasury Stock		Additional Paid-In Capital		Accumulated Deficit		Non- Controlling Interest
	Shares	Amount		Shares	Amount		Amount								Total
BALANCE AT MARCH 31, 2023	14,071,431	$	1	695,694,794	$	717	$	(810)	$	406,029	$	(439,639)	$	—	$	(33,702)
Net Loss Attributable to Unrivaled Brands, Inc.	—	—		—	—		—		—		(1,442)		—		(1,442)
Stock Compensation - Services Expense	—	—		79,997,091	80		—		1,473		—		—		1,553
Stock Option Expense	—	—		—	—		—		89		—		—		89
Forfeiture and Cancellation of Treasury Stock	—	—		(3,208,420)	—		810		(810)		—		—		—
BALANCE AT JUNE 30, 2023	14,071,431	$	1	772,483,465	$	797	$	—	$	406,781	$	(441,081)	$	—	$	(33,502)


	Convertible Series V Preferred Stock			Common Stock			Treasury Stock		Additional Paid-In Capital		Accumulated Deficit		Non- Controlling Interest
	Shares	Amount		Shares	Amount		Amount								Total
BALANCE AT MARCH 31, 2022	—	$	—	530,329,995	$	552	$	(808)	$	399,536	$	(258,888)	$	4,134	$	144,526
Net Loss Attributable to Unrivaled Brands, Inc.	—	—		—	—		—		—		(63,718)		—		(63,718)
Disposition of Non-Controlling Interest	—	—		—	—		—		—		(1,103)		(4,134)		(5,237)
Stock Compensation - Employees	—	—		1,200,000	1		—		169		—		—		170
Stock Compensation - Directors	—	—		259,796	—		—		29		—		—		29
Stock Compensation - Services Expense	—	—		725,000	1		—		128		—		—		129
Stock Option Expense	—	—		—	—		—		1,352		—		—		1,352
BALANCE AT JUNE 30, 2022	—	$	—	532,514,791	$	554	$	(808)	$	401,214	$	(323,709)	$	—	$	77,251

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

UNRIVALED BRANDS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY (UNAUDITED)

FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND 2022

(in thousands, except for shares)


	Convertible Series V						Treasury		Additional Paid-In Capital		Accumulated Deficit		Non- Controlling Interest		Total
	Preferred Stock			Common Stock			Stock
	Shares	Amount		Shares	Amount		Amount
BALANCE AT DECEMBER 31, 2022	—	$	—	679,513,564	$	701	$	(808)	$	403,619	$	(440,049)	$	—	$	(36,537)
Net Loss Attributable to Unrivaled Brands, Inc.	—	—		—	—		—		—		(1,032)		—		(1,032)
Stock Compensation - Services Expense	—	—		96,178,321	96		—		1,814		—		—		1,910
Stock Option Exercise	—	—		—	—		—		187		—		—		187
Stock Issued for Cash	14,071,431	1		—	—		—		1,969		—		—		1,970
Forfeiture and Cancellation of Treasury Stock	—	—		(3,208,420)	—		808		(808)		—		—		—
BALANCE AT JUNE 30, 2023	14,071,431	$	1	772,483,465	$	797	$	—	$	406,781	$	(441,081)	$	—	$	(33,502)

	Convertible Series V						Treasury		Additional Paid-In Capital		Accumulated Deficit		Non- Controlling Interest		Total
	Preferred Stock			Common Stock			Stock
	Shares	Amount		Shares	Amount		Amount
BALANCE AT DECEMBER 31, 2021	—	$	—	498,546,291	$	521	$	(808)	$	392,930	$	(250,015)	$	3,859	$	146,487
Net Loss Attributable to Unrivaled Brands, Inc.	—	—		—	—		—		—		(72,591)		—		(72,591)
Debt Conversion - Common Stock	—	—		294,452	—		—		75		—		—		75
Warrants Exercise	—	—		4,759,708	4		—		(5)		—		—		(1)
Stock Compensation - Employees	—	—		2,100,000	2		—		350		—		—		352
Stock Compensation - Directors	—	—		943,128	1		—		212		—		—		213
Stock Compensation - Services Expense	—	—		725,000	1		—		128		—		—		129
Stock Option Exercise	—	—		146,212	—		—		—		—		—		—
Stock Issued for Cash	—	—		25,000,000	25		—		4,350		—		—		4,375
Stock Option Expense	—	—		—	—		—		3,174		—		—		3,174
Disposition of Non-Controlling Interest	—	—		—	—		—		—		(1,103)		(4,134)		(5,237)
Net Loss Attributable to Non-Controlling Interest	—	—		—	—		—		—		—		275		275
BALANCE AT JUNE 30, 2022	—	$	—	532,514,791	$	554	$	(808)	$	401,214	$	(323,709)	$	—	$	77,251

The accompanying notes are an integral part of the unaudited consolidated financial statements.

UNRIVALED BRANDS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)


	Six Months Ended June 30,
	2023		2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$	(1,032)	$	(72,316)
Less: Net Income from Discontinued Operations	—		3,349
Net Loss from Continuing Operations	(1,032)		(75,665)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Deferred Income Tax Benefit	—		(2,137)
Bad Debt (Recovery) Expense	(7)		1,220
Gain on Settlement of Liabilities	(110)		—
Realized Loss on Sale of Investments	61		—
Gain on Extinguishment of Debt	(3,026)		(542)
Non-Cash Interest Expense	193		676
(Gain) Loss on Disposal of Assets	(1,739)		343
Depreciation and Amortization	1,558		6,602
Amortization of Operating Lease Right-of-Use Asset	999		1,080
Stock-Based Compensation	2,097		3,868
Unrealized Gain on Investments	—		(963)
Impairment Loss	—		55,726
Change in Operating Assets and Liabilities:
Accounts Receivable	(542)		2,434
Inventory	(1,013)		434
Prepaid Expenses and Other Current Assets	(193)		(1,885)
Other Assets	—		(2,520)
Accounts Payable and Accrued Expenses	1,256		9,776
Operating Lease Liabilities	(647)		200
Net Cash Used in Operating Activities - Continuing Operations	(2,145)		(1,353)
Net Cash Used in Operating Activities - Discontinued Operations	—		(1,150)
NET CASH USED IN OPERATING ACTIVITIES	(2,145)		(2,503)

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of Property and Equipment	(91)		(2,035)
Proceeds from Notes Receivable	634		375
Proceeds from Sale of Investments	149		—
Proceeds from Sale of Assets	—		450
Net Cash Provided by (Used in) Investing Activities - Continuing Operations	692		(1,210)
Net Cash Provided by Investing Activities - Discontinued Operations	—		20,709
NET CASH PROVIDED BY INVESTING ACTIVITIES	692		19,499

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of Debt Principal	(1,129)		(21,634)
Proceeds from Issuance of Common Stock	1,970		4,375
Net Cash Provided by (Used in) Financing Activities - Continuing Operations	841		(17,259)
Net Cash Used in Financing Activities - Discontinued Operations	—		(11)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	841		(17,270)

NET CHANGE IN CASH	(612)		(274)

Cash at Beginning of Period	1,200		6,700
Cash Reclassed to Discontinued Operations	—		(442)
CASH AT END OF PERIOD	$	588	$	5,984

SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:
Cash Paid for Interest	$	182	$	1,552

SUPPLEMENTAL DISCLOSURE FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:
Debt Principal and Accrued Interest Converted into Common Stock	$	—	$	52
Reclass of Accrued Interest to Principal	$	1,896	$	—
Net Assets Transferred to Assets Held For Sale	$	—	$	1,328

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

UNRIVALED BRANDS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1 – DESCRIPTION OF BUSINESS

Unrivaled Brands, Inc. (the “Company”) is a cannabis company with operations in retail, production, distribution, and cultivation throughout California, with an emphasis on providing the highest quality of medical and adult use cannabis products. The Company is home to Korova, a brand of high potency products across multiple product categories, currently available in California, Oregon, Arizona, and Oklahoma. With the acquisition of People’s First Choice, the Company operates a premier cannabis dispensary in Orange County, California. The Company also owns dispensaries in California which operate as The Spot in Santa Ana, Blüm in Oakland, and Blüm in San Leandro.

Unrivaled is a holding company with the following subsidiaries:

•121 North Fourth Street, LLC, a Nevada limited liability company (“121 North Fourth”)

•620 Dyer LLC, a California corporation (“Dyer”)

•1815 Carnegie LLC, a California limited liability company (“Carnegie”)

•Black Oak Gallery, a California corporation (“Black Oak”)

•Blüm San Leandro, a California corporation (“Blüm San Leandro”)

•Halladay Holding, LLC, a California limited liability company (“Halladay”)

•People’s First Choice, LLC, a California limited liability company (“People’s”)

•UMBRLA, Inc., a Nevada corporation ("UMBRLA")

References in this document to the “Company”, “Unrivaled”, “we”, “us”, or “our” are intended to mean Unrivaled Brands, Inc., individually, or as the context requires, collectively with its subsidiaries on a consolidated basis.

During the fiscal second quarter of 2023, the Company received confirmation for the legal dissolution of UMBRLA, Inc. As a result, all liabilities and existing obligations of the dissolved entity were extinguished and the Company recognized a gain on disposal of assets of $1.74 million during the three and six months ended June 30, 2023.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and with the instructions to U.S. Securities and Exchange Commission (“SEC”) Form 10-Q and Article 10 of Regulation S-X of the Securities Act of 1933 and reflect the accounts and operations of the Company and those of its subsidiaries in which the Company has a controlling financial interest. In accordance with the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 810, “Consolidation,” the Company consolidates any variable interest entity (“VIE”) of which it is the primary beneficiary. The typical condition for a controlling financial interest ownership is holding a majority of the voting interests of an entity; however, a controlling financial interest may also exist in entities, such as VIEs, through arrangements that do not involve controlling voting interests. ASC 810 requires a variable interest holder to consolidate a VIE if that party has the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. The Company does not consolidate a VIE in which it has a majority ownership interest when it is not considered the primary beneficiary. The Company evaluates its relationships with all the VIEs on an ongoing basis to reassess if it continues to be the primary beneficiary.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of June 30, 2023 and December 31, 2022, and the consolidated results of operations and cash flows for the periods ended June 30, 2023 and 2022 have been included. These interim unaudited condensed consolidated financial statements do not include all disclosures required by GAAP for complete financial statements and, therefore, should be read in conjunction with the more detailed audited consolidated financial statements for the year ended December 31, 2022. The December 31, 2022 balances reported herein are derived from the audited consolidated financial statements for the year ended December 31, 2022. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current period presentation. Specifically, the Company determined the presentation of promotion and marketing program ("PMP") revenue should be included as revenue. Prior period presentation of PMP was included as a component of other income in the consolidated statement of operations. In addition, the Company determined certain amounts pertaining to the gain on settlement of liabilities should be a categorized as a component of selling, general and administrative expenses. These reclassifications did not affect total assets, total liabilities, stockholders' deficit or net loss.

Going Concern

The Company incurred a pre-tax net loss from continuing operations of $1.57 million and $0.50 million for the three and six months ended June 30, 2023, respectively, and $65.59 million and $77.80 million for the three and six months ended June 30, 2022, respectively. As of June 30, 2023 and December 31, 2022, the Company had an accumulated deficit of $441.08 million and $440.05 million, respectively. At June 30, 2023, the Company had a consolidated cash balance of $0.59 million. Management expects to experience further net losses in 2023 and in the foreseeable future. The Company may not be able to generate sufficient cash from operating activities to fund its ongoing operations. The Company's future success is dependent upon its ability to achieve profitable operations and generate cash from operating activities. There is no guarantee that the Company will be able to generate enough revenue or raise capital to support its operations.

The Company will be required to raise additional funds through public or private financing, additional collaborative relationships or other arrangements until it is able to raise revenues to a point of positive cash flow. The Company is evaluating various options to further reduce its cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling common stock. There is no guarantee that it will be able to generate enough revenue or raise capital to support its operations, or if it is able to raise capital, that it will be available to the Company on acceptable terms, on an acceptable schedule, or at all.

The issuance of additional securities may result in a significant dilution in the equity interests of the Company's current stockholders. Obtaining loans, assuming these loans would be available, will increase the Company's liabilities and future cash commitments. There is no assurance that the Company will be able to obtain further funds required for its continued operations or that additional financing will be available for use when needed or, if available, that it can be obtained on commercially reasonable terms. If the Company is not able to obtain the additional financing on a timely basis, it will not be able to meet its other obligations as they become due and the Company will be forced to scale down or perhaps even cease its operations.

The risks and uncertainties surrounding the Company's ability to continue to raise capital and its limited capital resources raise substantial doubt as to the Company's ability to continue as a going concern for twelve months from the issuance of these financial statements.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. In an effort to achieve liquidity that would be sufficient to meet all of its commitments, the Company has undertaken a number of actions, including minimizing capital expenditures and reducing recurring expenses. However, management believes that even after taking these actions, the Company will not have sufficient liquidity to satisfy all of its future financial obligations. The risks and uncertainties surrounding the ability to raise capital, the limited capital resources, and the weak industry conditions impacting the Company’s business raise substantial doubt as to its ability to continue as a going concern.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

Significant Accounting Policies

The significant accounting policies and critical estimates applied by the Company in these interim unaudited condensed consolidated financial statements are the same as those applied in the Company’s audited consolidated financial statements and accompanying notes included in the Company’s 2022 Form 10-K, unless otherwise disclosed in these accompanying notes to the unaudited consolidated financial statements for the interim period ended June 30, 2023.

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the dates of the financial statements and the reported amounts of total net revenue and expenses in the reporting periods. The Company regularly evaluates estimates and assumptions related to revenue recognition, allowances for doubtful accounts, sales returns, inventory valuation, stock-based compensation expense, goodwill and purchased intangible asset valuations, derivative liabilities, deferred income tax asset valuation allowances, uncertain tax positions, tax contingencies, litigation and other loss contingencies.

These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenue, costs and expenses that are not readily apparent from other sources. The actual results the Company experiences may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected.

Loss Per Common Share

In accordance with the provisions of ASC 260, “Earnings Per Share”, net loss per share is computed by dividing net income or loss by the weighted-average shares of common stock outstanding during the period. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock, and convertible debt are not considered in the diluted loss per share calculation since the effect would be anti-dilutive. If the Company is in a net income position, diluted earnings per share includes stock options, warrants, convertible preferred stock, and convertible debt that are determined to be dilutive using the treasury stock method for all equity instruments issuable in equity units and the “if converted” method for the Company’s convertible debt. The Company's operations resulted in net loss for the three and six months ended June 30, 2023 and 2022. Therefore, the basic and diluted weighted-average shares of common stock outstanding were the same for all periods presented.

Dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):


	Six Months Ended June 30,
	2023	2022

Common Stock Warrants	100,918,457	85,826,872
Common Stock Options	21,125,759	88,126,615
	122,044,216	173,953,487

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

Recently Adopted Accounting Standards

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Subtopic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (“ASU 2021-08”), which is intended to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022. This update should be applied prospectively on or after the effective date of the amendments. The adoption of the standard did not have a material impact on the Company’s consolidated financial statements.

In March 2022, the FASB issued ASU 2022-02, “Financial Instruments—Credit Losses (Topic 326) Troubled Debt Restructurings and Vintage Disclosures” (“ASU 2022-02”), which eliminates the accounting guidance on troubled debt restructurings for creditors and amends the guidance on “vintage disclosures” to require disclosure of current-period gross write-offs by year of origination. The ASU also updates the requirements related to accounting for credit losses under the current guidance and adds enhanced disclosures for creditors with respect to loan refinancings and restructurings for borrowers experiencing financial difficulty. ASU 2022-02 is effective for fiscal years beginning after December 15, 2022. The adoption of the standard did not have a material impact on the Company’s consolidated financial statements.

In June 2016, the FASB ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326) – Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 replaces the “incurred loss” credit losses framework with a new accounting standard that requires management's measurement of the allowance for credit losses to be based on a broader range of reasonable and supportable information for lifetime credit loss estimates. Effective January 1, 2023, the Company adopted the standard. The adoption of this standard do not have a material impact on our financial statements.

Recently Issued Accounting Standards

In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurements—Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820)”. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. It also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. For public business entities, the ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the effect of adopting this ASU.

NOTE 3 – CONCENTRATIONS OF BUSINESS AND CREDIT RISK

The Company maintains cash balances in several financial institutions that are insured by either the Federal Deposit Insurance Corporation or the National Credit Union Association up to certain federal limitations. At times, the Company’s cash balance exceeds these federal limitations, and it maintains significant cash on hand at certain of its locations. The Company has not historically experienced any material loss from carrying cash on hand. The amount in excess of insured limitations was nil and nil as of June 30, 2023 and December 31, 2022, respectively.

The Company provides credit in the normal course of business to customers located throughout the U.S. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends, and other information. There were no customers that comprised more than 10.0% of the Company's revenue for the three and six months ended June 30, 2023 and 2022.

The Company sources cannabis products for retail, cultivation, and production from various vendors. However, as a result of regulations in the State of California, the Company’s California retail, cultivation, and production operations must use vendors licensed by the State. As a result, the Company is dependent upon the licensed vendors in California to supply products. If the Company is unable to enter into relationships with sufficient members of properly licensed vendors, the Company’s sales may be impacted. During the three and six months ended June 30, 2023 and 2022, the Company did not have any concentration of vendors for inventory purchases. However, this may change depending on the number of vendors who receive appropriate licenses to operate in the State of California.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

NOTE 4 – INVENTORY

Raw materials consist of materials and packaging for manufacturing of products owned by the Company. Work-in-progress consists of cultivation materials and live plants. Finished goods consists of cannabis products sold in retail and distribution. Inventory as of June 30, 2023 and December 31, 2022 consisted of the following:


	(in thousands)
	June 30, 2023		December 31, 2022

Raw Materials	$	674	$	524
Work-In-Progress	649		284
Finished Goods	1,629		1,131
Total Inventory	$	2,952	$	1,939

NOTE 5 – INVESTMENTS

On May 3, 2022, Edible Garden Corp. ("Edible Garden"), an entity in which the Company had an investment of common stock, completed a 1-for-5 reverse stock split of its outstanding common stock. As a result, the Company held 1,000,000 shares in Edible Garden. On May 5, 2022, Edible Garden announced the pricing of its initial public offering of 2,930,000 shares of its common stock and accompanying warrants to purchase up to 2,930,000 shares of common stock for an exercise price of $5.00 per share. Each share of common stock was sold together with one warrant at a combined offering price of $5.00, for gross proceeds of approximately $14.70 million. As a result of the initial public offering, the Company reassessed its write down on the investment and recorded a write up to its fair value, which is categorized within the fair value hierarchy as Level 2. In November 2022, the lock-up restriction on the Company's shares in Edible Garden expired and accordingly, the Company's investment transferred from Level 2 to Level 1 fair value measurement. During the fiscal first quarter ended March 31, 2023, the Company sold all its shares in Edible Garden and received $0.15 million. As a result, the Company recorded a realized loss on the sale of investments of $0.06 million during the six months ended June 30, 2023. During the six months ended June 30, 2022, the Company recorded nil in realized or unrealized losses related to its investment in Edible Garden.

NOTE 6 – PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS

Property, equipment, and leasehold improvements as of June 30, 2023 and December 31, 2022 consisted of the following:


	(in thousands)
	June 30, 2023		December 31, 2022

Land and Building	$	7,581	$	7,581
Furniture and Equipment	1,314		1,336
Computer Hardware	334		299
Leasehold Improvements	7,901		8,009
Vehicles	57		103
Construction in Progress	2,565		2,565
Subtotal	19,752		19,893
Less Accumulated Depreciation	(7,175)		(6,893)
Property, Equipment and Leasehold Improvements, Net	$	12,577	$	13,000

Depreciation expense related to continuing operations was $0.22 million and $0.93 million for the three months ended June 30, 2023 and 2022, respectively, and $0.43 million and $1.84 million for the six months ended June 30, 2023 and 2022, respectively.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

NOTE 7 – INTANGIBLE ASSETS

Intangible assets as of June 30, 2023 and December 31, 2022 consisted of the following:


		(in thousands)
		June 30, 2023						December 31, 2022
	Estimated Useful Life in Years	Gross Carrying Amount		Accumulated Amortization		Net Carrying Value		Gross Carrying Amount		Accumulated Amortization		Net Carrying Value

Amortizing Intangible Assets:
Customer Relationships	3 to 5	$	7,400	$	(7,400)	$	—	$	7,400	$	(7,400)	$	—
Trademarks and Patent	2 to 8	4,500		(4,116)		384		4,500		(2,991)		1,509
Operating Licenses	14	12,239		(12,239)		—		12,239		(12,239)		—
Total Amortizing Intangible Assets		24,139		(23,755)		384		24,139		(22,630)		1,509

Non-Amortizing Intangible Assets:
Trade Name	Indefinite	1,350		—		1,350		1,350		—		1,350
Total Non-Amortizing Intangible Assets		1,350		—		1,350		1,350		—		1,350
Total Intangible Assets, Net		$	25,489	$	(23,755)	$	1,734	$	25,489	$	(22,630)	$	2,859

Amortization expense related to continuing operations was $0.56 million and $2.42 million for the three months ended June 30, 2023 and 2022, respectively, and $1.13 million and $4.77 million for the six months ended June 30, 2023 and 2022, respectively.

NOTE 8 – GOODWILL

As of June 30, 2023, changes in the carrying amount of goodwill during the period presented were as follows:


	(in thousands)

Balance as of December 31, 2022	$	3,585
Balance as of June 30, 2023	$	3,585

The Company conducts its annual goodwill impairment assessment on September 30, and between annual tests if the Company becomes aware of an event or a change in circumstances that would indicate the carrying value may be impaired. Management did not identify any impairment triggers during the three and six months ended June 30, 2023 and concluded there was no impairment of goodwill.

For the purpose of the goodwill impairment assessment, the Company has the option to perform a qualitative assessment (commonly referred to as “step zero”) to determine whether further quantitative analysis for impairment of goodwill or indefinite-lived intangible assets is necessary or a quantitative assessment (“step one”) where the Company estimates the fair value of each reporting unit using a discounted cash flow method (income approach). Goodwill is assigned to the reporting unit, which is the operating segment level or one level below the operating segment. The balance of goodwill at June 30, 2023 and December 31, 2022 remained unchanged at $3.59 million.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

NOTE 9 – ACCRUED LIABILITIES

Accrued liabilities consisted of the following:


	(in thousands)
	June 30, 2023		December 31, 2022

Tax Liabilities	$	2,663	$	1,018
Accrued Payroll and Benefits	602		628
Accrued Interest	1,053		2,113
Other Accrued Expenses	1,290		665
Total Accrued Liabilities	$	5,608	$	4,424

NOTE 10 – LEASES

A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. Operating lease right-of-use assets are included in other assets while lease liabilities are a line item on the Company’s consolidated balance sheets. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Most operating leases contain renewal options that provide for rent increases based on prevailing market conditions. The terms used to calculate the right-of-use assets for certain properties include the renewal options that the Company is reasonably certain to exercise.

The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not readily determinable, the Company utilizes its secured borrowing rate. Right-of-use assets include any lease payments required to be made prior to commencement and exclude lease incentives. Both right-of-use assets and lease liabilities exclude variable payments not based on an index or rate, which are treated as period costs. The Company’s lease agreements do not contain significant residual value guarantees, restrictions or covenants.

The Company occupies office facilities under lease agreements that expire at various dates. In addition, office, production and transportation equipment is leased under agreements that expire at various dates. The Company does not have any significant finance leases. Total operating lease costs were $0.86 million and $1.37 million for the three months ended June 30, 2023 and 2022, respectively, and $1.50 million and $2.47 million for the six months ended June 30, 2023 and 2022, respectively. Short-term lease costs during the fiscal quarters ended June 30, 2023 and 2022 were not material.

As of June 30, 2023 and December 31, 2022, the Company has short-term lease liabilities of $2.13 million and $2.00 million, respectively. The table below presents total operating lease right-of-use assets and lease liabilities as of June 30, 2023 and December 31, 2022:


	(in thousands)
	June 30, 2023		December 31, 2022
Operating Lease Right-of-Use Assets	$	12,946	$	13,946
Operating Lease Liabilities	$	14,437	$	15,084

The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use assets:


	Six Months Ended
	June 30, 2023		June 30, 2022
Weighted Average Remaining Lease Term (Years)	8.0		5.7
Weighted Average Discount Rate	11.7	%	11.4	%

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

NOTE 11 – NOTES PAYABLE

Notes payable as of June 30, 2023 and December 31, 2022 consisted of the following:


	(in thousands)
	June 30, 2023		December 31, 2022
Promissory note dated May 4, 2020, issued to Harvest Small Business Finance, LLC, an unaffiliated third party. Loan was part of the Paycheck Protection Program ("PPP Loan") offered by the U.S. Small Business Administration. The interest rate on the note was 1.0%. The note required interest and principal payments seven months from July 2020. The note matures in February 2025.	$	14	$	14
Convertible promissory note dated January 25, 2021, issued to accredited investors, which matured July 22, 2022 and bears interest at a rate of 8.0% per annum. The conversion price is $0.175 per share.	3,253		3,450
Promissory note dated July 27, 2021, issued to Arthur Chan which matures July 26, 2024, and bears interest at a rate of 8.0% per annum.	2,500		2,500
Unsecured promissory note dated December 28, 2022 due to a related party. The interest rate on the note is 1.0% and matures on December 28, 2027.	94		154
Promissory note dated October 1, 2021, issued to Sterling Harlan as part of the SilverStreak Solutions acquisition. The interest rate on the note was 10.0%. The note matures in March 2028.	308		2,000
Promissory note dated October 1, 2021, issued to Sterling Harlan as part of the SilverStreak Solutions acquisition. The interest rate on the note was 10.0%. The note matures in March 2028.	1,230		2,500
Secured promissory notes dated March 6, 2023 issued to People's California, LLC, which matures in March 2028 and bears interest at a rate of 10.0% per annum on the first $3.00 million due in December 2023, and 5.0% per annum on the remaining balance through September 2023 and 10.0% per annum thereafter. Payment of the remaining balance is due in March 2028.	22,200		21,569
Promissory note dated May 1, 2019, assumed by the Company on July 1, 2021 in connection with the purchase of real property, from a related party. The note matures on May 15, 2039 and bears interest at a rate of 9.9% per year.	2,876		2,882
Notes Payable - Promissory Notes	$	32,475	$	35,069
Vehicle Loans	57		76
Less: Short-Term Debt	(25,879)		(29,662)
Less: Debt Discount, Net	(11)		(669)
Net Long-Term Debt	$	6,642	$	4,814

Amendments of Promissory Note Related to People's California, LLC

On March 6, 2023, the Company entered into a binding settlement term sheet ("Settlement Term Sheet") to resolve pending litigation matters with People’s California, LLC, whereby the parties agreed to amend the terms of that certain secured promissory note ("Original Note"), issued by the Company to People's California, LLC on November 22, 2021. The Original Note was amended and restated into two secured promissory notes: a $3.00 million note ("$3M Note") and a $20.00 million note ("Settlement Note"). The $3M Note accrues simple interest at 10.0% annually, interest payable monthly in cash, and principal is due 180 days after effective date of the Settlement Term Sheet.

The Settlement Note accrues interest at 5.0% for the first 180 days, and 10.0% thereafter, interest is paid in cash (or the Company’s common stock based on the 10-day volume-weighted average price ("VWAP") at the date of issuance) starting 180 days after the effective date of the Settlement Term Sheet and on the first of the month thereafter. The amount of $5.00 million of principal is due in cash within 90 days of the effective date of the Settlement Term Sheet with the balance due on the fifth anniversary of the effective date of the Settlement Term Sheet, which is March 6, 2028. When the $5.00 million principal payment for the Settlement Note and the $3.00 million payment under the $3M Note are paid (“Up-front Settlement”) in accordance with the Settlement Term Sheet, People's California, LLC will be obligated to transfer the Riverside and Costa Mesa licenses and stores to the Company as described in that certain membership interest purchase agreement, dated as of November 22, 2021, with People's California, LLC for no additional consideration.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

On the earlier of the date of the Up-front Settlement payment or 180 days after the effective date of the Settlement Term Sheet, People's California, LLC will have the option to convert a portion or all of the principal balance of the Settlement Note into the Company's common stock subject to certain requirements in the Settlement Term Sheet. The conversion price is the lower of $0.20 or the 10-day VWAP of the Company's common stock. Upon payment of the Up-front Settlement, the Company has the option to convert the unpaid principal balance of either notes into the Company's common stock at a conversion price of $0.20 per share as long as the at the time of the conversion the Company's common stock has a 10-day VWAP of $0.20 per share or greater.

After the first $5.00 million principal payment on the Settlement Note, principal payments made in cash prior to the first anniversary of the Settlement Term Sheet reduce the principal balance by twice the amount of the cash payment. The modification to the Company's promissory note under the Settlement Term Sheet was classified as troubled debt restructuring pursuant to ASC 470-60, "Troubled Debt Restructurings by Debtors" ("ASC 470-60") and the Company recorded a premium of $0.47 million. See "Note 18 – Commitments and Contingencies" for details on the related litigation matters.

On May 17, 2023, the Company amended the Settlement Term Sheet wherein the maturity date of the $3M Note was extended to December 6, 2023 and payments of the $5.00 million portion of the Up-front Settlement was extended through September 6, 2023, with $0.80 million being due and paid in cash on May 18, 2023. In addition, the Company shall make an additional $2.20 million principal repayment on or before July 6, 2023. Monthly interest payments were amended to provide the Company with the option to pay 50% of interest in the form of registered shares of common stock. Further, upon payment of the $0.80 million on May 18, 2023, People's California, LLC shall transfer the Riverside and Costa Mesa licenses and stores to the Company for no additional consideration. Such assets have not been transferred to the Company as of June 30, 2023 and the Company has not recorded a debt premium for the contingent free assets. The amendment to the Settlement Term Sheet was classified as a troubled debt restructuring pursuant to ASC 470-60.

On July 10, 2023, the Company received a notice of breach and demand to cure from People's California, LLC in respect of the Settlement Term Sheet, as amended on May 17, 2023, wherein People’s California, LLC stated that the Company failed to make the principal repayment of $2.20 million on July 6, 2023 and a monthly interest payment of $25,000 for the month of June 2023. As a result, the promissory notes became callable by the creditor subsequent to the balance sheet date but before these consolidated financial statements are issued. Accordingly, the Company classified the long-term debt as current notes payable in the consolidated balance sheet as of June 30, 2023. The Company is currently in ongoing discussions with People's California, LLC to renegotiate the debt.

Amendment of Promissory Notes Related to SilverStreak Acquisition

On March 23, 2023, the Company entered into a binding term sheet to modify the terms of the $2.00 million and $2.50 million unsecured promissory notes originally issued on October 1, 2021 in connection with that certain stock purchase agreement dated June 9, 2021 and amended on July 13, 2021, which reduced the principal to an aggregate of $1.25 million, with required monthly aggregate payments of approximately $0.03 million, interest of 10% per annum, and maturing on March 15, 2028 ("Notes Modification"). The parties also agreed that the Company shall be responsible for certain tax liabilities of approximately $0.53 million. The Notes Modification was classified as a troubled debt restructuring pursuant to ASC 470-60, "Troubled Debt Restructurings by Debtors," and the Company recorded a gain on extinguishment of debt of $3.03 million and reduced the carrying value of the promissory notes to total future cash payments of $1.59 million.

On April 30, 2023, the Company entered into a Settlement Agreement and Release (the “Settlement Agreement”) as definitive documentation of the binding term sheet dated March 23, 2023 related to the unsecured promissory notes issued on October 1, 2021 in connection with the acquisition of SilverStreak Solutions, Inc.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

NOTE 12 – STOCKHOLDERS' DEFICIT

Series V Preferred Stock

In December 2022, the Company filed a Certificate of Designation of Rights, Privileges, Preferences, and Restrictions with the Secretary of State of the State of Nevada to establish a new class of preferred shares, the Series V Preferred Stock, $0.001 par value. The number of authorized shares of Series V Preferred Stock is 25,000,000 shares. Each share of Series V Preferred Stock is convertible into ten shares of Common Stock at any time from and after the first anniversary of the issuance date. Each share of Series V Preferred Stock will automatically be converted into ten fully paid and non-assessable shares of Common Stock on the second anniversary of the date on which the holder’s shares of Series V Preferred Stock were issued. The Series V Class of Preferred Stock have a one-year lock-up and have a two times voting right which automatically expires in two years.

In January 2023, the Company entered into Securities Purchase Agreements with certain investors, including Sabas Carrillo, the Company’s Chief Executive Officer, Patty Chan, the Company’s Chief Financial Officer, James Miller, the Company's Chief Operating Officer, and Robert Baca, the Company’s Chief Legal Officer (the "Private Placement"). Pursuant to the SPA, the Company issued (i) 14,071,431 shares of Series V Preferred Stock at $0.14 per share which is equal to the closing share price of the Company’s common stock on December 30, 2022 on an as-converted-to-common stock-basis of ten shares of common stock for each one share of Series V Preferred Stock or $0.014 per share of common stock and (ii) 70,357,155 warrants to purchase up to 70,357,155 of common stock with an exercise price of $0.028 or equivalent to two times the as-converted-to-common stock purchase price of $0.014. The Company received total gross proceeds of $1.97 million from the Private Placement. The purchasers in the Private Placement entered into a voting agreement to assign their voting rights to Sabas Carrillo, the Company's Chief Executive Officer.

Series N Preferred Stock

In February 2023, the Company filed a Certificate of Designation of Rights, Privileges, Preferences, and Restrictions with the Secretary of State of the State of Nevada to establish a new class of preferred shares, the Series N Preferred Stock, $0.001 par value. The number of authorized shares of Series N Preferred Stock is 2,500,000 shares. Each share of Series N Preferred Stock is convertible into 100 shares of the Company's common stock at any time from and before the first anniversary of the issuance date. Each share of Series N Preferred Stock will automatically be converted into 100 fully paid and non-assessable shares of the Company's common stock on the first anniversary of the issuance date.

Common Stock

The Company authorized 990,000,000 shares of common stock with $0.001 par value per share. As of June 30, 2023 and December 31, 2022, 772,483,465 and 679,513,554 shares of common stock were outstanding, respectively.

During the six months ended June 30, 2023, the Company issued 96,178,321 shares of common stock to a related party service provider. As a result, the Company recorded $1.91 million of stock-based compensation expense for services during the six months ended June 30, 2023. See "Note 17 – Related Party Transactions" for further information.

During the six months ended June 30, 2023, a member of the Company's board of directors forfeited 900,000 shares of the Company's common stock to the Company for no cash value. Subsequent to the forfeiture, the Company cancelled 3,208,420 shares of treasury stock during the six months ended June 30, 2023. Accordingly, treasury stock outstanding as of June 30, 2023 and December 31, 2022 was nil and 2,308,420 shares of common stock, respectively.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

NOTE 13 – STOCK-BASED COMPENSATION

Equity Incentive Plans

In the first quarter of 2016, the Company adopted the 2016 Equity Incentive Plan. In the fourth quarter of 2018, the Company adopted the 2018 Equity Incentive Plan. In July 2021, the Company assumed the 2019 Equity Incentive Plan as part of the acquisition of UMBRLA. The following table contains information about the Company's equity incentive plans as of June 30, 2023:


	Awards Reserved for Issuance	Awards Exercised	Awards Outstanding	Awards Available for Grant

2016 Equity Incentive Plan	497,776	—	248,888	248,888
2018 Equity Incentive Plan	17,364,171	4,022,133	6,754,353	6,587,685
2019 Equity Incentive Plan	24,062,129	34,884	14,027,519	9,999,726

Stock-Based Compensation Expense

The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses:


	(in thousands, except for shares / options)
	For the Three Months Ended
	June 30, 2023			June 30, 2022
Type of Award	Number of Shares or Options Granted	Stock-Based Compensation Expense		Number of Shares or Options Granted	Stock-Based Compensation Expense

Stock Options	—	$	89	400,000	$	1,352

Stock Grants:
Employees (Common Stock)	—	—		1,200,000	170
Directors (Common Stock)	—	—		259,796	29
Non–Employee Consultants (Common Stock)	79,997,091	1,553		725,000	129

Total Stock–Based Compensation Expense		$	1,642		$	1,680


	(in thousands, except for shares / options)
	For the Six Months Ended
	June 30, 2023			June 30, 2022
Type of Award	Number of Shares or Options Granted	Stock-Based Compensation Expense		Number of Shares or Options Granted	Stock-Based Compensation Expense

Stock Options	—	$	187	400,000	$	3,174

Stock Grants:
Employees (Common Stock)	—	—		2,100,000	352
Directors (Common Stock)	—	—		943,128	213
Non–Employee Consultants (Common Stock)	96,178,321	1,910		725,000	129

Total Stock–Based Compensation Expense		$	2,097		$	3,868

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

Stock Options

The following table summarizes the Company’s stock option activity and related information for the six months ended June 30, 2023:


	Number of Shares	Weighted- Average Exercise Price Per Share		Weighted- Average Remaining Contractual Life	Aggregate Intrinsic Value of In-the-Money Options

Options Outstanding as of January 1, 2023	52,821,099	$	0.23
Forfeited	(31,695,340)	$	0.23
Options Outstanding as of June 30, 2023	21,125,759	$	0.23	7.1 years	$	—
Options Exercisable as of June 30, 2023	15,931,299	$	0.28	7.5 years	$	—

As of June 30, 2023, total unrecognized stock-based compensation was $0.21 million. Such costs are expected to be recognized over a weighted-average period of approximately 1.01 years. The Company recognizes compensation expense for stock option awards on a straight-line basis over the applicable service period of the award. The service period is generally the vesting period.

The Company does not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Hence, the Company uses the “simplified method” described in Staff Accounting Bulletin 107 to estimate the expected term of share option grants. The expected stock price volatility assumption was determined by examining the historical volatilities for the Company’s common stock. The Company will continue to analyze the historical stock price volatility and expected term assumptions as more historical data for the Company’s common stock becomes available. The risk-free interest rate assumption is based on the U.S. treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. The Company has never paid dividends on its common stock and does not anticipate paying dividends on its common stock in the foreseeable future. Accordingly, the Company has assumed no dividend yield for purposes of estimating the fair value of the Company stock-based compensation.

NOTE 14 – WARRANTS

The following table summarizes the Company's warrant activity for the six months ended June 30, 2023:


	Warrants	Weighted-Average Exercise Price

Warrants Outstanding as of January 1, 2023	80,881,817	$	0.11

Issued	70,357,155	$	0.03
Expired	(560,211)	$	2.43
Warrants Outstanding as of June 30, 2023	150,678,761	$	0.06

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

NOTE 15 – DISCONTINUED OPERATIONS

Oregon Operations

On December 28, 2022, the Company entered into a Stock Purchase and Sale Agreement pursuant to which the Company sold all of its equity interests in LTRMN, Inc., which conducts cannabis distribution and wholesale activities in Oregon, for an aggregate purchase price of $0.25 million. The purchase price was paid in the form of a secured promissory note at a rate of 8.0% per annum due and payable on the third anniversary of the date of issuance. However, upon a final and binding settlement of certain ongoing litigation that is approved by UMBRLA, the purchase price shall be automatically revised to be nil and the promissory note shall be deemed paid and satisfied in-full.

On December 28, 2022, the Company entered into a Membership Interest Purchase and Sale Agreement pursuant to which the Company sold its 50.0% equity interests in Psychonaut Oregon, LLC (“Psychonaut”) to Joseph Gerlach for an aggregate purchase price of $1.00. Mr. Gerlach owns the other 50.0% of the equity interests in Psychonaut and is also the Company’s Chief Cultivation Officer. In connection with the sale of Psychonaut, the Company entered into an unsecured promissory note dated December 28, 2022 (the “Psychonaut Note”) pursuant to which the Company consolidated all current liabilities due to Mr. Gerlach totaling $0.15 million. The Psychonaut Note accrues interest at a rate of 1.0% per annum and is due and payable on the fifth anniversary of the date of issuance.

The Company concluded that the sale of LTRMN, Inc. and Psychonaut (together, the "Oregon operations") represented a strategic shift that will have a major effect on the Company’s operations and financial results and thus all assets and liabilities allocable to the operations within the state of Oregon were classified as discontinued operations. The assets associated with the Oregon operations were measured at the lower of their carrying amount or fair value less costs to sell ("FVLCTS"). Revenue and expenses, gains or losses relating to the discontinuation of Oregon operations were eliminated from profit or loss from the Company’s continuing operations and are shown as a single line item in the consolidated statements of operations for all periods presented.

The Company recognized a loss upon sale of the Oregon operations of $0.50 million for the net carrying value of the assets as of the disposition date which was determined as the book value less direct costs to sell and is recognized as a component of loss on disposal of assets and other expense in the Consolidated Statements of Operations for Discontinued Operations during the year ended December 31, 2022. As of December 31, 2022, the Oregon operations have been fully deconsolidated by the Company and the Company does not have any continuing involvement with the former subsidiary outside of the Magee litigation disclosed in “Note 18 – Commitments and Contingencies”.

NuLeaf

On November 17, 2021, Medifarm III, LLC (“Medifarm III”), a wholly-owned subsidiary of the Company, entered into a Membership Interest Purchase Agreement (the “NuLeaf Purchase Agreement”) with NuLeaf, Inc., a Nevada corporation (“NuLeaf”). Upon the terms and subject to the satisfaction of the conditions described in the NuLeaf Purchase Agreement, Medifarm III agreed to sell its 50.0% of the outstanding membership interests of each of NuLeaf Reno Production, LLC (“NuLeaf Reno”) and NuLeaf Sparks Cultivation, LLC (“NuLeaf Sparks”) to NuLeaf, which owned the remaining 50.0% of the membership interests of NuLeaf Reno and NuLeaf Sparks, for aggregate consideration of $6.50 million in cash. The transaction closed in April 2022.

OneQor

During fiscal year 2020, management suspended the operations of OneQor due to (i) a lack of proper growth in customer acquisition and revenue for this CBD operation during the COVID-19 pandemic and (ii) the overall financial health of the Company as a result of COVID-19 and social unrest. The Company plans to focus its attention and resources on growing its THC business. In November 2022, the Company received confirmation for the legal dissolution of OneQor. Accordingly, all liabilities and existing obligations related to OneQor were extinguished as of December 31, 2022.

The completed sales of our NuLeaf and Oregon operations during the periods presented represented a strategic shift that had a major effect on the Company’s operations and financial results. As a result, management determined the results of these components qualified for discontinued operations presentation in accordance with ASC 205, “Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity".

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

Operating results for the discontinued operations were comprised of the following:


	(in thousands)
	Three Months Ended June 30,		Six Months Ended June 30,
	2022		2022
Total Revenues	$	1,948	$	6,833
Cost of Goods Sold	1,549		3,648
Gross Profit	399		3,185

Selling, General & Administrative Expenses	1,137		3,608
Gain on Sale of Assets	(2,047)		(3,728)
Income from Operations	1,309		3,305

Interest Expense	(6)		(6)
Other Income	21		50
Income from Discontinued Operations Before Provision for Income Taxes	1,324		3,349

Income Tax Expense	95		—
Income from Discontinued Operations	$	1,419	$	3,349

Income from Discontinued Operations per Common Share Attributable to Unrivaled Brands, Inc. Common Stockholders - Basic And Diluted	$	—	$	0.01

As of June 30, 2023 and December 31, 2022, the assets and liabilities related to discontinued operations were deconsolidated and no balance remained.

NOTE 16 – SEGMENT INFORMATION

The Company operates in two segments:

(i) Cannabis Retail – Either independently or in conjunction with third parties, the Company operates medical marijuana and adult use cannabis dispensaries in California. All retail dispensaries offer a broad selection of medical and adult use cannabis products including flower, concentrates, and edibles.

(ii) Cannabis Cultivation and Distribution – The Company operates a cultivation facility in Oakland, California and distributes flower grown from the facility to other manufacturers or to its own retail cannabis dispensaries in California under the Korova brand.

For the periods presented, revenue by reportable segments are as follows:


	(in thousands)								(in thousands)
	Total Revenue				% of Total Revenue				Total Revenue				% of Total Revenue
	Three Months Ended June 30,								Six Months Ended June 30,
Segment	2023		2022		2023		2022		2023		2022		2023		2022
Cannabis Retail	$	8,415	$	11,140	95.7	%	70.5	%	$	16,885	$	23,653	93.6	%	68.3	%
Cannabis Cultivation & Distribution	382		4,661		4.3	%	29.5	%	1,152		10,997		6.4	%	31.7	%

Total	$	8,797	$	15,801	100.0	%	100.0	%	$	18,037	$	34,650	100.0	%	100.0	%

The accompanying notes are an integral part of the unaudited consolidated financial statements.

Table of Contents

For the periods presented, results of operations by reportable segments are as follows:


	(in thousands)
	Three Months Ended June 30, 2023										Three Months Ended June 30, 2022
	Cannabis Retail			Cannabis Cultivation & Distribution			Corporate & Other		Total		Cannabis Retail			Cannabis Cultivation & Distribution			Corporate & Other		Total
Total Revenues	$	8,415		$	382		$	—	$	8,797	$	11,140		$	4,661		$	—	$	15,801
Cost of Goods Sold	3,963			234			—		4,197		5,430			2,284			—		7,714
Gross Profit	4,452			148			—		4,600		5,710			2,377			—		8,087
Gross Profit %	52.9		%	38.7		%					51.3		%	51.0		%

Selling, General & Administrative Expenses	2,852			312			4,907		8,071		6,427			3,886			7,847		18,160
Impairment Expense	—			—			—		—		—			—			55,726		55,726
(Gain) Loss on Disposal of Assets	—			—			(1,739)		(1,739)		542			—			(1)		541
Income (Loss) from Operations	1,600			(164)			(3,168)		(1,732)		(1,259)			(1,509)			(63,572)		(66,340)

Other Income (Expense):
Interest Income (Expense)	48			—			(235)		(187)		—			(11)			(427)		(438)
Gain on Settlement of Liabilities	110			—			—		110		—			—			—		—
Unrealized Gain on Investments	—			—			—		—		—			—			963		963
Other Income (Expense)	(31)			9			264		242		(71)			112			189		230
Total Other Income (Expense), Net	127			9			29		165		(71)			101			725		755

Income (Loss) Before Provision for Income Taxes	$	1,727		$	(155)		$	(3,139)	$	(1,567)	$	(1,330)		$	(1,408)		$	(62,847)	$	(65,585)

Total Assets (Liabilities)	$	18,231		$	4,456